Role of Cholinergic Signaling in Alzheimer's Disease

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2022 Mar 26

PMID 35335180

Authors

Zhi-Ru Chen

Jia-Bao Huang

Shu-Long Yang

Fen-Fang Hong

Affiliations

Soon will be listed here.

Abstract

Acetylcholine, a neurotransmitter secreted by cholinergic neurons, is involved in signal transduction related to memory and learning ability. Alzheimer's disease (AD), a progressive and commonly diagnosed neurodegenerative disease, is characterized by memory and cognitive decline and behavioral disorders. The pathogenesis of AD is complex and remains unclear, being affected by various factors. The cholinergic hypothesis is the earliest theory about the pathogenesis of AD. Cholinergic atrophy and cognitive decline are accelerated in age-related neurodegenerative diseases such as AD. In addition, abnormal central cholinergic changes can also induce abnormal phosphorylation of ttau protein, nerve cell inflammation, cell apoptosis, and other pathological phenomena, but the exact mechanism of action is still unclear. Due to the complex and unclear pathogenesis, effective methods to prevent and treat AD are unavailable, and research to explore novel therapeutic drugs is various and active in the world. This review summaries the role of cholinergic signaling and the correlation between the cholinergic signaling pathway with other risk factors in AD and provides the latest research about the efficient therapeutic drugs and treatment of AD.

Citing Articles

EnSCAN: ENsemble Scoring for prioritizing CAusative variaNts across multiplatform GWASs for late-onset alzheimer's disease.

Erdogan O, Iyigun C, Aydin Son Y BioData Min. 2025; 18(1):20.

PMID: 40038746 PMC: 11881353. DOI: 10.1186/s13040-025-00436-x.

Extract optimization of Ulva lactuca L. and biological activities of optimized extracts.

Korkmaz N BMC Biotechnol. 2025; 25(1):21.

PMID: 40038659 PMC: 11881367. DOI: 10.1186/s12896-025-00954-w.

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.

Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W Signal Transduct Target Ther. 2025; 10(1):74.

PMID: 40038239 PMC: 11880366. DOI: 10.1038/s41392-024-02107-5.

Gut microbiome synthesizes important core metabolites to prevent cognitive decline and mitigate onset and progression of Alzheimer's disease.

Al-Abbas N, Shaer N J Alzheimers Dis Rep. 2025; 8(1):1705-1721.

PMID: 40034366 PMC: 11863740. DOI: 10.1177/25424823241309024.

Gintonin Binds to Reduced LPA4 Receptor Subtype in Human Cortical Neurons in Alzheimer's Disease Brains.

Kim K, Lee R, Park I, Hwang S, Kim Y, Jang J Biomolecules. 2025; 15(2).

PMID: 40001482 PMC: 11853258. DOI: 10.3390/biom15020179.

References

Agatonovic-Kustrin S, Kettle C, Morton D . A molecular approach in drug development for Alzheimer's disease. Biomed Pharmacother. 2018; 106:553-565. DOI: 10.1016/j.biopha.2018.06.147. View

Ren Z, Dong Z, Xie P, Lv J, Hu Y, Guan Z . PNU282987 inhibits amyloid‑β aggregation by upregulating astrocytic endogenous αB‑crystallin and HSP‑70 via regulation of the α7AChR, PI3K/Akt/HSF‑1 signaling axis. Mol Med Rep. 2020; 22(1):201-208. PMC: 7248489. DOI: 10.3892/mmr.2020.11132. View

Park H, Kwon H, Lee J, Cho E, Lee Y, Moon M . β-Amyrin Ameliorates Alzheimer's Disease-Like Aberrant Synaptic Plasticity in the Mouse Hippocampus. Biomol Ther (Seoul). 2019; 28(1):74-82. PMC: 6939697. DOI: 10.4062/biomolther.2019.024. View

Lecrux C, Sandoe C, Neupane S, Kropf P, Toussay X, Tong X . Impact of Altered Cholinergic Tones on the Neurovascular Coupling Response to Whisker Stimulation. J Neurosci. 2017; 37(6):1518-1531. PMC: 6705676. DOI: 10.1523/JNEUROSCI.1784-16.2016. View

Jha A, Panchal S, Shah A . Ellagic acid: Insights into its neuroprotective and cognitive enhancement effects in sporadic Alzheimer's disease. Pharmacol Biochem Behav. 2018; 175:33-46. DOI: 10.1016/j.pbb.2018.08.007. View

Xia E, Xu F, Hu C, Kumal J, Tang X, Mao D . Young Blood Rescues the Cognition of Alzheimer's Model Mice by Restoring the Hippocampal Cholinergic Circuit. Neuroscience. 2019; 417:57-69. DOI: 10.1016/j.neuroscience.2019.08.010. View

Liu P, Xie Y, Meng X, Kang J . History and progress of hypotheses and clinical trials for Alzheimer's disease. Signal Transduct Target Ther. 2019; 4:29. PMC: 6799833. DOI: 10.1038/s41392-019-0063-8. View

Ali B, Jamal Q, Shams S, Al-Wabel N, Siddiqui M, Alzohairy M . In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment. CNS Neurol Disord Drug Targets. 2016; 15(5):624-8. DOI: 10.2174/1871527315666160321110607. View

Kwakowsky A, Milne M, Waldvogel H, Faull R . Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease. Int J Mol Sci. 2016; 17(12). PMC: 5187922. DOI: 10.3390/ijms17122122. View

10.

Kumar R, Nordberg A, Darreh-Shori T . Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs. Brain. 2015; 139(Pt 1):174-92. PMC: 4949388. DOI: 10.1093/brain/awv318. View

11.

Eivani M, Alijanpour S, Arefian E, Rezayof A . Corticolimbic analysis of microRNAs and protein expressions in scopolamine-induced memory loss under stress. Neurobiol Learn Mem. 2019; 164:107065. DOI: 10.1016/j.nlm.2019.107065. View

12.

Abe K . [Nicotinic acetylcholine receptor in Alzheimer's disease]. Nihon Rinsho. 2013; 71(4):743-50. View

13.

Llorente-Ovejero A, Martinez-Gardeazabal J, Moreno-Rodriguez M, Lombardero L, Gonzalez de San Roman E, Manuel I . Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease. ACS Chem Neurosci. 2021; 12(12):2167-2181. PMC: 9162383. DOI: 10.1021/acschemneuro.1c00169. View

14.

Goshadrou F, Sadeghi B . Nucleus basalis of Meynert modulates signal processing in rat layer 5 somatosensory cortex but leads to memory impairment and tactile discrimination deficits following lesion. Behav Brain Res. 2020; 386:112608. DOI: 10.1016/j.bbr.2020.112608. View

15.

Chang W, Pedroni A, Bertuzzi M, Kizil C, Simon A, Ampatzis K . Locomotion dependent neuron-glia interactions control neurogenesis and regeneration in the adult zebrafish spinal cord. Nat Commun. 2021; 12(1):4857. PMC: 8357999. DOI: 10.1038/s41467-021-25052-1. View

16.

Olive I, Makris N, Densmore M, McKinnon M, Lanius R . Altered basal forebrain BOLD signal variability at rest in posttraumatic stress disorder: A potential candidate vulnerability mechanism for neurodegeneration in PTSD. Hum Brain Mapp. 2021; 42(11):3561-3575. PMC: 8249881. DOI: 10.1002/hbm.25454. View

17.

Ray B, Maloney B, Sambamurti K, Karnati H, Nelson P, Greig N . Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease. Transl Psychiatry. 2020; 10(1):47. PMC: 7026402. DOI: 10.1038/s41398-020-0709-x. View

18.

Sun Y, Wu A, Li X, Qin D, Jin B, Liu J . The seed of fraction ameliorates hippocampal neuronal injury in an Aβ-induced Alzheimer's disease rat model via the AKT/GSK-3β pathway. Pharm Biol. 2019; 58(1):35-43. PMC: 6968628. DOI: 10.1080/13880209.2019.1697298. View

19.

Gregory J, Vengalasetti Y, Bredesen D, Rao R . Neuroprotective Herbs for the Management of Alzheimer's Disease. Biomolecules. 2021; 11(4). PMC: 8068256. DOI: 10.3390/biom11040543. View

20.

Paz M, Barrantes F . Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets. ACS Chem Neurosci. 2019; 10(5):2186-2194. DOI: 10.1021/acschemneuro.9b00041. View